Senti Biosciences, Inc.(SNTI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SNTI Senti Biosciences, Inc.

已收盘 03-06 16:00:00 EST

0.9649

+0.0268

+2.86%

盘后0.9303

-0.0346-3.59%

19:42 EST

最高0.9760	最低0.9101	成交量15.26万
今开0.9150	昨收0.9381	日振幅7.02%
总市值2,524万	流通市值923.96万	总股本2,616万
成交额14.18万	换手率1.59%	流通股本957.57万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SNTI","market":"US","secType":"STK","nameCN":"Senti Biosciences, Inc.","latestPrice":0.9649,"timestamp":1772830800000,"preClose":0.9381,"halted":0,"volume":152583,"hourTrading":{"tag":"盘后","latestPrice":0.9303,"preClose":0.9649,"latestTime":"19:42 EST","volume":1979,"amount":1846.1934,"timestamp":1772844129210,"change":-0.0346,"changeRate":-0.035859,"amplitude":0.035859},"delay":0,"changeRate":0.028568382901609565,"floatShares":9575679,"shares":26160206,"eps":-2.87,"marketStatus":"已收盘","change":0.0268,"latestTime":"03-06 16:00:00 EST","open":0.915,"high":0.976,"low":0.9101,"amount":141768.30909830998,"amplitude":0.070248,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.87,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1773043200000},"marketStatusCode":5,"adr":0,"listingDate":1622001600000,"exchange":"NASDAQ","adjPreClose":0.9381,"preHourTrading":{"tag":"盘前","latestPrice":0.915,"preClose":0.9381,"latestTime":"09:28 EST","volume":3846,"amount":3533.3032776,"timestamp":1772807298390,"change":-0.0231,"changeRate":-0.024624,"amplitude":0.058309},"postHourTrading":{"tag":"盘后","latestPrice":0.9303,"preClose":0.9649,"latestTime":"19:42 EST","volume":1979,"amount":1846.1934,"timestamp":1772844129210,"change":-0.0346,"changeRate":-0.035859,"amplitude":0.035859},"volumeRatio":1.554071},"requestUrl":"/m/hq/s/SNTI","defaultTab":"news","newsList":[{"id":"2614886305","title":"Senti Biosciences, Inc.盘中异动 早盘股价大涨5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614886305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614886305?lang=zh_cn&edition=full","pubTime":"2026-02-27 00:28","pubTimestamp":1772123324,"startTime":"0","endTime":"0","summary":"北京时间2026年02月27日00时28分，Senti Biosciences, Inc.股票出现异动，股价急速拉升5.71%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为2.24%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家处于临床阶段的生物技术公司，致力于开发下一代细胞和基因疗法，这些疗法利用其基因回路平台技术为患有不治之症的患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227002844954224e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227002844954224e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNTI","BK4539"],"gpt_icon":0},{"id":"2610494802","title":"Senti Biosciences, Inc.盘中异动 股价大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610494802","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610494802?lang=zh_cn&edition=full","pubTime":"2026-02-11 22:32","pubTimestamp":1770820340,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日22时32分，Senti Biosciences, Inc.股票出现波动，股价急速上涨5.31%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家处于临床阶段的生物技术公司，致力于开发下一代细胞和基因疗法，这些疗法利用其基因回路平台技术为患有不治之症的患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021122322097a5d1ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021122322097a5d1ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNTI","BK4139","BK4539"],"gpt_icon":0},{"id":"1151179337","title":"Senti Biosciences完成针对复发或难治性急性髓系白血病（R/R AML）的Senti-202一期临床试验患者招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1151179337","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151179337?lang=zh_cn&edition=full","pubTime":"2026-02-11 21:35","pubTimestamp":1770816922,"startTime":"0","endTime":"0","summary":"Senti Biosciences, Inc. 已顺利完成其候选疗法Senti-202针对复发或难治性急性髓系白血病（R/R AML）的一期临床试验患者招募工作。这一关键进展标志着该疗法向临床开发的下一个阶段迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","SNTI","BK4139"],"gpt_icon":0},{"id":"2605875482","title":"Senti Biosciences, Inc.盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605875482","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605875482?lang=zh_cn&edition=full","pubTime":"2026-01-24 00:16","pubTimestamp":1769185019,"startTime":"0","endTime":"0","summary":"北京时间2026年01月24日00时16分，Senti Biosciences, Inc.股票出现波动，股价大幅下挫5.15%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家处于临床阶段的生物技术公司，致力于开发下一代细胞和基因疗法，这些疗法利用其基因回路平台技术为患有不治之症的患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124001659a44f1a7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124001659a44f1a7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNTI","BK4539","BK4139"],"gpt_icon":0},{"id":"2590347834","title":"美股异动 | 1期SENTI-202试验数据积极 Senti Biosciences(SNTI.US)开盘涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590347834","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590347834?lang=zh_cn&edition=full","pubTime":"2025-12-09 22:45","pubTimestamp":1765291511,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周二，Senti Biosciences(SNTI.US)开盘涨超7%，报2.54美元。消息面上，Senti Bio报告了更新的1期SENTI-202在R/R AML中的数据，显示50%的总缓解率(ORR)、42%的完全缓解/部分血液学缓解(CR/CRh)，且大多数为微小残留病阴性(MRD-Negative)持久应答，并获得RMAT支持以推进至关键研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379602.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美股异动 | 1期SENTI-202试验数据积极 Senti Biosciences(SNTI.US)开盘涨超7%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SNTI","BK4539","BK4139"],"gpt_icon":0},{"id":"1105566673","title":"Senti Bio获得FDA再生医学先进疗法(RMAT)认证，Senti-202用于治疗成人复发性或难治性急性髓系白血病","url":"https://stock-news.laohu8.com/highlight/detail?id=1105566673","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105566673?lang=zh_cn&edition=full","pubTime":"2025-12-09 20:02","pubTimestamp":1765281749,"startTime":"0","endTime":"0","summary":"Senti Bio获得FDA再生医学先进疗法(RMAT)认证，Senti-202用于治疗成人复发性或难治性急性髓系白血病","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNTI","BK4539"],"gpt_icon":0},{"id":"2588041089","title":"Senti Biosciences, Inc.盘中异动 股价大涨5.34%报2.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588041089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588041089?lang=zh_cn&edition=full","pubTime":"2025-12-03 04:35","pubTimestamp":1764707752,"startTime":"0","endTime":"0","summary":"北京时间2025年12月03日04时35分，Senti Biosciences, Inc.股票出现波动，股价急速拉升5.34%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家处于临床阶段的生物技术公司，致力于开发下一代细胞和基因疗法，这些疗法利用其基因回路平台技术为患有不治之症的患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203043552a4c8b600&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203043552a4c8b600&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNTI","BK4539","BK4139"],"gpt_icon":0},{"id":"1180501700","title":"Senti Biosciences第三季度净收入为-1812.6万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1180501700","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180501700?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:45","pubTimestamp":1763574338,"startTime":"0","endTime":"0","summary":"11月13日 - Senti Biosciences第三季度运营费用为1694.8万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNTI","BK4539","BK4139"],"gpt_icon":0},{"id":"1155513651","title":"Senti Bio公布2025年第三季度财务业绩，并确认将在12月美国血液学会年会上发布急性髓性白血病（Aml）Phase 1 Senti-202研究的下一批临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1155513651","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155513651?lang=zh_cn&edition=full","pubTime":"2025-11-14 05:31","pubTimestamp":1763069475,"startTime":"0","endTime":"0","summary":"Senti Bio公布了2025年第三季度的财务业绩，并确认将在12月的美国血液学会年会上发布其急性髓性白血病（Aml）Phase 1 Senti-202研究的下一批临床数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNTI","BK4539","BK4139"],"gpt_icon":0},{"id":"2583456755","title":"Senti Biosciences, Inc.盘中异动 股价大涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583456755","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583456755?lang=zh_cn&edition=full","pubTime":"2025-11-13 23:10","pubTimestamp":1763046635,"startTime":"0","endTime":"0","summary":"北京时间2025年11月13日23时10分，Senti Biosciences, Inc.股票出现异动，股价急速拉升5.29%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家处于临床阶段的生物技术公司，致力于开发下一代细胞和基因疗法，这些疗法利用其基因回路平台技术为患有不治之症的患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111323103595027e68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111323103595027e68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNTI","BK4539"],"gpt_icon":0},{"id":"2578542907","title":"Senti Biosciences, Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578542907","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578542907?lang=zh_cn&edition=full","pubTime":"2025-10-24 22:06","pubTimestamp":1761314799,"startTime":"0","endTime":"0","summary":"北京时间2025年10月24日22时06分，Senti Biosciences, Inc.股票出现波动，股价大幅拉升5.00%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家处于临床阶段的生物技术公司，致力于开发下一代细胞和基因疗法，这些疗法利用其基因回路平台技术为患有不治之症的患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024220639a6cc3d91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024220639a6cc3d91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","SNTI"],"gpt_icon":0},{"id":"2577348833","title":"Senti Biosciences, Inc.盘中异动 早盘大幅下挫5.85%报1.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577348833","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577348833?lang=zh_cn&edition=full","pubTime":"2025-10-22 22:49","pubTimestamp":1761144565,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日22时49分，Senti Biosciences, Inc.股票出现异动，股价急速下挫5.85%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家处于临床阶段的生物技术公司，致力于开发下一代细胞和基因疗法，这些疗法利用其基因回路平台技术为患有不治之症的患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022224925a46ec786&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022224925a46ec786&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNTI","BK4539"],"gpt_icon":0},{"id":"2575242578","title":"Senti Biosciences, Inc.盘中异动 早盘股价大涨5.34%报1.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575242578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575242578?lang=zh_cn&edition=full","pubTime":"2025-10-14 21:31","pubTimestamp":1760448687,"startTime":"0","endTime":"0","summary":"北京时间2025年10月14日21时31分，Senti Biosciences, Inc.股票出现异动，股价快速上涨5.34%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家处于临床阶段的生物技术公司，致力于开发下一代细胞和基因疗法，这些疗法利用其基因回路平台技术为患有不治之症的患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014213128972d97f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014213128972d97f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","SNTI"],"gpt_icon":0},{"id":"2574107224","title":"Senti Biosciences, Inc.盘中异动 早盘急速下跌6.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574107224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574107224?lang=zh_cn&edition=full","pubTime":"2025-10-10 21:55","pubTimestamp":1760104553,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日21时55分，Senti Biosciences, Inc.股票出现波动，股价大幅下跌6.05%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家处于临床阶段的生物技术公司，致力于开发下一代细胞和基因疗法，这些疗法利用其基因回路平台技术为患有不治之症的患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101021555394c1fa30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101021555394c1fa30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNTI","BK4139","BK4539"],"gpt_icon":0},{"id":"2518717227","title":"Senti Biosciences, Inc.股价重挫10.51% 市值跌159.89万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518717227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518717227?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:35","pubTimestamp":1741613722,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时35分，Senti Biosciences, Inc.股票出现异动，股价快速下跌10.51%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Trevi Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2175.89%、425.85%、66.65%，振幅较大的相关个股有Akero Therapeutics, Inc.、Seer, Inc.、珐博进，振幅分别为100.05%、98.72%、98.49%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家临床阶段生物技术公司，利用其基因电路平台技术开发下一代细胞和基因疗法，以对抗挑战性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213522abf2fdc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213522abf2fdc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNTI","BK4539","BK4139"],"gpt_icon":0},{"id":"2517161945","title":"Senti Biosciences, Inc.盘中异动 早盘股价大涨8.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517161945?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:49","pubTimestamp":1741186165,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时49分，Senti Biosciences, Inc.股票出现波动，股价大幅拉升8.68%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.51%。其相关个股中，Chimerix, Inc.、Silexion Therapeutics Corp、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为595.83%、267.83%、215.60%，振幅较大的相关个股有Nkgen Biotech, Inc.、Silexion Therapeutics Corp、Aditxt, Inc.，振幅分别为40.77%、33.33%、23.90%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家临床阶段生物技术公司，利用其基因电路平台技术开发下一代细胞和基因疗法，以对抗挑战性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224925989d49f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224925989d49f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","SNTI"],"gpt_icon":0},{"id":"2516652680","title":"Senti Biosciences, Inc.盘中异动 股价大跌6.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516652680","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516652680?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:33","pubTimestamp":1741026790,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时33分，Senti Biosciences, Inc.股票出现波动，股价急速下挫6.98%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4396.71%、193.31%、179.43%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家临床阶段生物技术公司，利用其基因电路平台技术开发下一代细胞和基因疗法，以对抗挑战性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023310a25d84fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023310a25d84fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","SNTI"],"gpt_icon":0},{"id":"2514837892","title":"Senti Biosciences, Inc.盘中异动 股价大跌5.46%报3.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514837892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514837892?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:39","pubTimestamp":1740753580,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时39分，Senti Biosciences, Inc.股票出现波动，股价大幅下挫5.46%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家临床阶段生物技术公司，利用其基因电路平台技术开发下一代细胞和基因疗法，以对抗挑战性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223940abe0ecfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223940abe0ecfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNTI","BK4139","BK4539"],"gpt_icon":0},{"id":"2514384007","title":"Senti Biosciences, Inc.盘中异动 早盘快速下挫5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514384007","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514384007?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:03","pubTimestamp":1740672239,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时03分，Senti Biosciences, Inc.股票出现波动，股价大幅跳水5.99%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家临床阶段生物技术公司，利用其基因电路平台技术开发下一代细胞和基因疗法，以对抗挑战性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280004009632c4d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280004009632c4d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","SNTI","BK4139"],"gpt_icon":0},{"id":"2514019392","title":"Senti Biosciences, Inc.盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514019392","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514019392?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:00","pubTimestamp":1740499202,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时00分，Senti Biosciences, Inc.股票出现波动，股价快速下跌5.21%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1203.46%、1099.45%、758.15%，振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Adial Pharmaceuticals, Inc，振幅分别为224.93%、87.83%、64.05%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家临床阶段生物技术公司，利用其基因电路平台技术开发下一代细胞和基因疗法，以对抗挑战性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600000298925fdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600000298925fdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","SNTI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sentibio.com","stockEarnings":[{"period":"1week","weight":-0.0437},{"period":"1month","weight":-0.0428},{"period":"3month","weight":-0.5596},{"period":"6month","weight":-0.3251},{"period":"1year","weight":-0.7041},{"period":"ytd","weight":-0.098}],"compareEarnings":[{"period":"1week","weight":-0.0116},{"period":"1month","weight":-0.0119},{"period":"3month","weight":-0.0064},{"period":"6month","weight":0.0526},{"period":"1year","weight":0.1685},{"period":"ytd","weight":-0.0009}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Senti Biosciences, Inc.于2021年3月1日在特拉华州成立。该公司是一家临床前生物技术公司，开发利用其基因电路平台技术设计的下一代细胞和基因疗法，以对抗具有挑战性的疾病。该公司的使命是创造新一代更智能的疗法，以传统药物无法实现的方式战胜复杂疾病。为了完成这一使命，Senti Biosciences建立了一个合成生物学平台，认为该平台可能使其能够利用所谓的“基因回路”对下一代细胞和基因疗法进行编程。这些基因回路由Senti Biosciences用新颖和专有的基因部分组合创建，旨在用生物学逻辑对细胞进行重新编程，以感知输入、计算决策并对各自的细胞环境做出反应。Senti Biosciences基因电路平台技术可以以模式无关的方式应用，适用于自然杀伤细胞、T细胞、肿瘤浸润淋巴细胞、包括造血干细胞在内的干细胞、体内基因治疗和信使核糖核酸。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.037903},{"month":2,"riseRate":0.2,"avgChangeRate":-0.117173},{"month":3,"riseRate":0.2,"avgChangeRate":-0.047052},{"month":4,"riseRate":0.25,"avgChangeRate":-0.055926},{"month":5,"riseRate":0.25,"avgChangeRate":-0.078726},{"month":6,"riseRate":0,"avgChangeRate":-0.301397},{"month":7,"riseRate":0.4,"avgChangeRate":0.120052},{"month":8,"riseRate":0.4,"avgChangeRate":-0.119944},{"month":9,"riseRate":0.4,"avgChangeRate":-0.088688},{"month":10,"riseRate":0.6,"avgChangeRate":0.032318},{"month":11,"riseRate":0.4,"avgChangeRate":0.12033},{"month":12,"riseRate":0.4,"avgChangeRate":0.047383}],"exchange":"NASDAQ","name":"Senti Biosciences, Inc.","nameEN":"Senti Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Senti Biosciences, Inc.(SNTI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Senti Biosciences, Inc.(SNTI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Senti Biosciences, Inc.,SNTI,Senti Biosciences, Inc.股票,Senti Biosciences, Inc.股票老虎,Senti Biosciences, Inc.股票老虎国际,Senti Biosciences, Inc.行情,Senti Biosciences, Inc.股票行情,Senti Biosciences, Inc.股价,Senti Biosciences, Inc.股市,Senti Biosciences, Inc.股票价格,Senti Biosciences, Inc.股票交易,Senti Biosciences, Inc.股票购买,Senti Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Senti Biosciences, Inc.(SNTI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Senti Biosciences, Inc.(SNTI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}